Active Ingredient: SUMATRIPTAN SUCCINATE
Proprietary Name: SUMATRIPTAN SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077907
Product Number: 001
Approval Date: Feb 6, 2009
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:
Discontinued
Patent and Exclusivity Information
